AzTrials
AzTrials

Mental Health IssueUPICNCT06490120

A Study on Young Individuals' Mental Health in Sweden

An observational study of Mental Health Issue and Depression, Anxiety, run by Uppsala University at 1 site in Sweden.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to increase our knowledge about the mental health of young individuals and to establish a valid and comprehensive method for assessing mental health in young individuals (15-29 years) that can improve our capacity to promote mental health and address mental health problems. Read more about this study

Who is it for?
Ages 15 to 29 yearsHealthy volunteers can take part
What is being tested?
sampling method
How many people
3,000 participants
Where
1 siteSweden
Study dates
12 Aug 2024to 31 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Men and women in the general population in Sweden aged 15-29 years at recruitment

Who may be able to join

  • age at recruitment
  • ownership of smartphone

Who cannot join

  • N/A

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pernilla Asenlof, PhD contact

+ 46 18 471 47 68

pernilla.asenlof@uu.se

Sweden1 site
  • Uppsala University

    Uppsala

    Pernilla Åsenlöf, Prof, 0704562831, pernilla.asenlof@uu.se

Other trials in Sweden

About this study

Official title: En Longitudinell Observationsstudie om Unga Individers Psykiska hälsa i Sverige

The goal of this observational study is to increase our knowledge about the mental health of young individuals and to establish a valid and comprehensive method for assessing mental health in young individuals (15-29 years) that can improve our capacity to promote mental health and address mental health problems.

The specific aims of the proposed project are: 1) To determine the extent and course of mental health in young men and women over a two-year period and discern the added value of multimodal data to assess and predict mental health problems. 2) To demonstrate the feasibility of different assessment methods of mental health in young individuals.

Read more

Participants will be able to provide:

  • Survey data - mental health outcome measures are used to assess mental well-being and mental health problems, and sociodemographic and individual health data are collected to explore potential confounders with the primary outcomes.
  • Behavioral testing - online/remote behavioral assessments such as approach-avoidance conflict, emotional regulation, risk-taking-attitude and cognitive tests.
  • National register data - sociodemographic data including age, country of birth, education, school absence, sickness absence and income, inpatient (hospital) and outpatient specialist care, information on e.g. psychiatric conditions and pain conditions and psychiatric care and use of psychotropic medication.
  • Blood-based biological marker - monitoring of about 800 biomarkers, carefully selected to target the most important metabolic pathways, including steroid-, hormone-, neurotransmitter- and lipid regulation.
  • Passive data by digital phenotyping - automatically collected data from for example smartphone sensors and activity logs.
  • App- and survey metadata - app usage, when a survey was opened, time taken to answer separate measures and questions, completion of full survey, and any changes made in survey responses.

Researchers will compare 3 different assessment protocols, with participants providing data at different time points, this in order to see demonstrate feasibility and methods for future studies on mental health in young individuals. Establishment of feasibility is done by collecting data on: recruitment rate, adherence and acceptance of study procedures including mode of data collection.

Read the detailed description

In Sweden, reports show an increase in mental health problems of young people, in particular of young women. This increase is poorly understood, calling for more rigorous studies to clarify extent and severity of the problems, but also, to inform practices on how to adequately assess youth mental health.

The purpose of this project is to increase our knowledge about the mental health of young women and men and to establish a valid and comprehensive method for assessing mental health in young individuals that can improve our capacity to promote mental health and address mental health problems. A multimodal data approach is applied, comprising a feasibility study on methods of assessment of mental health in young individuals.

The specific aims of the proposed project are: 1) To determine the extent and course of mental health in young women and men over a two-year period and discern the added value of multimodal data to assess and predict mental health problems. 2) To demonstrate the feasibility of different assessment methods of mental health in young women and men. Establishment of feasibility is done by collecting data on: recruitment rate, adherence and acceptance of study procedures including mode of data collection.

There is a common opinion in Sweden and internationally that mental health problems have increased over the past decades. More research is needed to understand this proposed increase in mental health problems and to clarify if the reports reflect a genuine deterioration in mental health. Existing studies have been criticized for not being able to provide reliable estimates of mental health problems due to heterogeneity in study designs and limitations including lack of use of established, comprehensive measures. The national surveys that indicate a deterioration of mental health in young women in Sweden rely on reports from single questions. Although less respondent burden, the validity and reliability of using single questions to assess concepts such as anxiety and depression can be disputed. Moreover, existing studies provide cross-sectional point estimates rather than prospective time lines, which generally result in more accurate and reliable data.

Traditional methodologies with sole reliance on self-reported data to provide accurate and reliable estimates to better understand mental health of young women may not be the way forward. For instance, metabolomics biomarkers taken from for example blood or urine have gained interest for its ability to screen new and unsuspected pathways involved in psychiatric disorders, and fear conditioning and extinction protocols as well as behavioural testing of e.g. avoidance and distress tolerance have shown promise in detecting and predicting mental health. Combining self-report data with information from such other data sources presents a promising approach, yet the use of multimodal data is an understudied area in mental health research. Moreover, with the ubiquity of smartphones along with advances in technology, it is now possible to use digital devices such as smartphones to assess and track certain behaviours, which makes it possible to address some of the drawbacks of traditional assessment methods. Behavioural real-time data on e.g., participant's symptoms, functions, and social environment in nonclinical settings collected from digital devices holds considerable potential for detecting, understanding and predicting psychiatric conditions, mood disorders, and depressive symptoms.

This feasibility study consists of a prospective cohort using a multimodal data approach. The same theoretical framework, procedure, data collection and measurements apply to both Aim 1 and Aim 2.

Design Three assessment protocols will be evaluated. After baseline assessment, participants will be randomly assigned to a protocol on a 1:1:1 basis. Considering participant dropout after baseline and with an aim to include 750 young individuals per protocol, recruitment will continue until the target number of 200 young individuals per year of birth at baseline (n=3000) is reached. The proposed sample size is based on our primary feasibility outcome: complete adherence of the protocol. Assuming 90% power and alpha=0.05, at least 500 young individuals are needed to adhere to each protocol to detect a 10% statistically significant difference in adherence between protocols, e.g. 60% adherent young individuals assigned to protocol 1 and 2, who complete follow-up, compared with 50% adherent young individuals assigned to protocol 3.

Data collection Data from different modalities will be combined, including both active and passive data. Specifically, data will be collected by survey, smartphone sensor data, at-home blood sampling, behavioural tests, and register data. Most data will be administered via a study-specific app. Written (electronic) consent will be obtained before participation. For instance, a participant may consent to participation with survey data, sensor data, and behavioural tests, but not with blood sample or linkage to register data. Incentives will be offered to participants at completion of an assessment.

In protocol 1, mental health is assessed by survey on three occasions: at baseline and follow-ups at 1 and 2 years later. This design with yearly assessments is congruent with conventional methods of assessment by survey. To investigate the potential benefits as well as risks of more frequent assessments, data will be collected in the same way in protocol 2, but on five occasions: at baseline and 6, 12, 18 and 24 months later. In protocol 3, in addition to yearly assessments by survey, a real-time data capture method referred to as ecological momentary assessments (EMA) will be applied. After the baseline assessment, participants in protocol 3 will asked to complete daily registrations using a selection of self-report measures during a one-month period. The self-report questions will be distributed via the application with about 15-20 questions at a time. This EMA schedule will be repeated three times over the study period.

Data analysis plan The number of young individuals who indicate caseness (according to available scoring guides) of depressive symptoms based on survey responses will be determined to assess prevalence and developmental trajectories of self-reported mental health problems over the two-year follow-up time. Mental health profiles will be mapped with the use of information from the different types of data. The statistical techniques applied for identification of symptom patterns, relationships and determinants of mental health problems and well-being will be suited to complex longitudinal and multimodal data, such as structural equation modelling, generalized linear (mixed) models, and Bayesian modelling. To study time series of symptom occurrence clusters of longitudinally reported symptoms will be obtained by unsupervised clustering analysis.

Based on previous studies on mental health in youth, a point of reference of >20% for baseline recruitment rate will be considered feasible. Dropout analysis will target representativeness at baseline and throughout the phases of the study. At baseline, the distributions of sociodemographic data obtained by register data will be analysed between participants and nonparticipants. For identification of attrition bias, dropout analysis will consider sociodemographic register data but also analyse distributions of health outcomes from previous assessments among participants and dropouts at later stages of the study.

An adherence rate of >50% during the two-year follow-up will be considered feasible, and will be evaluated for each assessment protocol. For the EMA outcomes (protocol 3), the recording and reporting of compliance data will follow the published recommendations, including the measurement of compliance rate as number of prompts answered out of the total number of prompts delivered (compliance of ≥80% feasible) and latency (time period between when participants receive a prompt and when the EMA is answered). Based on previous survey studies on mental health in Sweden, an overall compliance of >75% will be considered feasible. A feasible acceptance rate of behaviour experiments in this heterogeneous, nonclinical population cannot be decided, but our results will clarify acceptance and completion rate for this kind of remotely delivered behavioural experiment. Based on preliminary results of the Mom2B study, an acceptance rate of >70% for access to passive data and 80% to register data will be considered feasible. Furthermore, the completion rate of each self-report measure will be calculated. Instrument guidelines will guide the analyses and interpretation, but if no guideline exists <10% internal missing per question/scale is considered feasible.

Expected outcome The prospective design allows detection of extent and severity of mental health problems in young individuals and will clarify the course of mental health during a two-year period. To clarify the added value of having more frequent assessment points to detect course of mental health is an important outcome of the present study. The results of the EMA assessments will reveal individual day-to-day variability across mental health symptoms and behaviors, expanding the knowledge of the underlying processes and dynamics of mental health. The results will demonstrate the utility of multimodal data for the assessment of mental health and show how outcomes from different data sources are interrelated. This, along with the identification of potential drawbacks of frequent assessments will guide future health assessment strategies. It also allows for data on the predictive value of health outcomes from different methods of assessment. Of particular interest is to demonstrate if multimodal data provide more comprehensive data than single data modality and to clarify if multimodal data improve precision in prediction of mental health problems.

Importantly, the results will demonstrate if an age- and sex-stratified recruitment strategy is appropriate or if selective recruitment methods are needed to obtain a representative population sample. The feasibility of collecting mental health data by self-report measures with 6-month and/or one year follow-up as well as with an EMA approach will be clarified. Results will also show if behavioural testing, passive data, blood sampling are feasible outcome tools to use as proposed.

Being tested
sampling method
Keywords
Mental Health, Trajectories, Multimodal, Young Individuals, Ecological momentary assessment
Medical subject headings
Depression, Anxiety Disorders, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • sampling methodOther

    feasibility outcomes will be compared between the 3 groups

Study groups in NCT06490120
Study groupRoleWhat they receive
Protocol 1Mental health is assessed over the course of 2 years, by survey on three occasions: at baseline and follow-ups at 1 and 2 years later.
Receives: Other: sampling method
Protocol 2Mental health is assessed over the course of 2 years, by survey on five occasions: at baseline and 6, 12, 18 and 24 months later.
Receives: Other: sampling method
Protocol 3Mental health is assessed over the course of 2 years, by survey on three occasions: at baseline and follow-ups at 1 and 2 years later. Additionally, a real-time data capture method, ecological momentary assessments (EMA) will be applied directly after baseline and 6, 12 and 18 months later. Participants in group 3 will asked to complete daily registrations using a selection of self-report measures during a one month period. The self-report questions will be distributed via the application with about 5 to 15 questions at a time.
Receives: Other: sampling method

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in anxiety symptoms

    Self-report: Generalised Anxiety Disorder (GAD-7). Swedish version. 7 items ranging from 0 ='not at all', to 3 ='almost every day'. 1 item ranging from 0 ='no difficulties, to 3 = 'extreme difficulties'. 1 item ranging from 0 ='not at all, to 3 = 'very disturbing'. The first 7 items are summed to a sum score ranging from 0 to 21, where: 0-4 = no signs of anxiety, 5-9 = mild GAD, 10-14 = moderate GAD, 15-21 = severe GAD. Item 8 is reported as a single item where higher score means higher interference.

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  2. Change in anxiety symptoms

    Self-report: Generalised Anxiety Disorder (GAD-7). Swedish version. 7 items ranging from 0 ='not at all', to 3 ='almost every day'. 1 item ranging from 0 ='no difficulties, to 3 = 'extreme difficulties'. 1 item ranging from 0 ='not at all, to 3 = 'very disturbing'. The first 7 items are summed to a sum score ranging from 0 to 21, where: 0-4 = no signs of anxiety, 5-9 = mild GAD, 10-14 = moderate GAD, 15-21 = severe GAD. Item 8 is reported as a single item where higher score means higher interference.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

  3. Change in depressive symptoms

    Self-report: Patient Health Questionnaire - 9 (PHQ-9+1), Swedish version. 9 items ranging from 0 ='not at all', to 3 ='almost every day'. 1 item ranging from 0 ='no difficulties, to 3 = 'extreme difficulties'. The first 9 items are summed to a sum score ranging from 0 to 27, where: 0-4 = no signs of depression, 5-9 = mild depression, 10-14 = moderate depression, 15-19 = moderately severe depression, 20-27 = severe depression. Item 10 is reported as a single item where high scores indicate high interference with daily function.

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  4. Change in depressive symptoms

    Self-report: Patient Health Questionnaire - 9 (PHQ-9+1), Swedish version. 9 items ranging from 0 ='not at all', to 3 ='almost every day'. 1 item ranging from 0 ='no difficulties, to 3 = 'extreme difficulties'. The first 9 items are summed to a sum score ranging from 0 to 27, where: 0-4 = no signs of depression, 5-9 = mild depression, 10-14 = moderate depression, 15-19 = moderately severe depression, 20-27 = severe depression. Item 10 is reported as a single item where high scores indicate high interference with daily function.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

  5. Change in well-being

    Self-report: Well-Being Index (WHO-5). Swedish version. 5 items ranging from 0 ='at no time', to 5 ='all the time'. The 5 items are summed to a score ranging from 0 to 25, 0 representing worst possible and 25 representing best possible quality of life.

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  6. Change in well-being

    Self-report: Well-Being Index (WHO-5). Swedish version. 5 items ranging from 0 ='at no time', to 5 ='all the time'. The 5 items are summed to a score ranging from 0 to 25, 0 representing worst possible and 25 representing best possible quality of life.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

Secondary outcomes (50)
  1. Change in emotional well-being

    Self-report: Mental Health Continuum Short Form (MHC-SF). Swedish version. 14 items which assesses how often a statement was true during the past two weeks, reported on a 6-point Likert scale ranging from 0 "never" to 5 "everyday". Statements include emotional, social, and psychological aspects of well-being. Items are summed, yielding a total score ranging from 0 to 70. The total scale score will be used for the assessment of overall mental well-being with higher scores indicating greater levels of positive well-being.

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  2. Change in emotional well-being

    Self-report: Mental Health Continuum Short Form (MHC-SF). Swedish version. 14 items which assesses how often a statement was true during the past two weeks, reported on a 6-point Likert scale ranging from 0 "never" to 5 "everyday". Statements include emotional, social, and psychological aspects of well-being. Items are summed, yielding a total score ranging from 0 to 70. The total scale score will be used for the assessment of overall mental well-being with higher scores indicating greater levels of positive well-being.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

  3. Change in stress

    Self-report: Perceived Stress Scale (PSS-10). Swedish version. 10 item ranging from 0 ='never' to 4 ='very often'. Scores for item 4, 5, 7 and 8 need to be reversed (0=4, 1=3, 2=2, 1=4) and all summed to a score ranging 0 to 40. Higher scores indicate higher level of perceived stress.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

  4. Change in stress

    Self-report: Perceived Stress Scale (PSS-10). Swedish version. 10 item ranging from 0 ='never' to 4 ='very often'. Scores for item 4, 5, 7 and 8 need to be reversed (0=4, 1=3, 2=2, 1=4) and all summed to a score ranging 0 to 40. Higher scores indicate higher level of perceived stress.

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  5. Change in sleep

    Self-report: The insomnia severity index (ISI). Swedish version. The ISI comprises 7 items that assess current (i.e., preceding 2 weeks) sleep problems. The first three items evaluate the severity of sleep onset, sleep maintenance, and early morning awakening problems. Subsequent items assess current sleep problem, interference with daily functioning, noticeability of impairment attributed to the sleep problem, and amount of worry due to the current sleep problem. Items are rated on a five-point Likert scale ('0' representing none or not at all and '4' representing very much). Total scores range from 0 to 28, with higher combined scores indicating worse insomnia severity.

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  6. Change in sleep

    Self-report: The insomnia severity index (ISI). Swedish version. The ISI comprises 7 items that assess current (i.e., preceding 2 weeks) sleep problems. The first three items evaluate the severity of sleep onset, sleep maintenance, and early morning awakening problems. Subsequent items assess current sleep problem, interference with daily functioning, noticeability of impairment attributed to the sleep problem, and amount of worry due to the current sleep problem. Items are rated on a five-point Likert scale ('0' representing none or not at all and '4' representing very much). Total scores range from 0 to 28, with higher combined scores indicating worse insomnia severity.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

  7. Change in psychological flexibility

    Self-report: Selected items from the Multidimensional Psychological Flexibility Inventory (MPFI). Swedish version. 12 items where rate how often they experience each statement during the last 2 weeks, with responses given on a 6-point scale ranging from never true (1) to always true (6).

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  8. Change in Psychological Flexibility

    Self-report: Selected items from the Multidimensional Psychological Flexibility Inventory (MPFI). Swedish version. 12 items where rate how often they experience each statement during the last 2 weeks, with responses given on a 6-point scale ranging from never true (1) to always true (6).

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

  9. Change in effortful control

    Self-report: The Adult Temperament Questionnaire (ATQ). Swedish version. 19 items where Each item is rated on a 7-point Likert scale, ranging from 1 = 'extremely untrue of you' to 7 = 'extremely true of you'.

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  10. Change in effortful control

    Self-report: The Adult Temperament Questionnaire (ATQ). Swedish version. 19 items where Each item is rated on a 7-point Likert scale, ranging from 1 = 'extremely untrue of you' to 7 = 'extremely true of you'.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

  11. Change in emotion regulation

    Self-report: The Adolescents' Emotion Regulation Strategies Questionnaire-Extended (AERSQ-E). Swedish version. 23 items with each item rated on a 5-point scale, ranging from 1 = 'very rarely/never' to 5 = 'very often/always'.

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  12. Change in emotion regulation

    Self-report: The Adolescents' Emotion Regulation Strategies Questionnaire-Extended (AERSQ-E). Swedish version. 23 items with each item rated on a 5-point scale, ranging from 1 = 'very rarely/never' to 5 = 'very often/always'.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

  13. Individual health data

    Self-report: height, weight, sexual health, menstrual bleeding pattern, physical health, psychological diagnosis and treatments.

    Measured: Baseline for Group 1, 2, 3

  14. Individual health data

    Self-report: height, weight, sexual health, menstrual bleeding pattern, physical health, psychological diagnosis and treatments.

    Measured: 6 months for Group 2

  15. Individual health data

    Self-report: height, weight, sexual health, menstrual bleeding pattern, physical health, psychological diagnosis and treatments.

    Measured: 1 year for Group 1, 2, 3

  16. Individual health data

    Self-report: height, weight, sexual health, menstrual bleeding pattern, physical health, psychological diagnosis and treatments.

    Measured: 1.5 year Group 2

  17. Individual health data

    Self-report: height, weight, sexual health, menstrual bleeding pattern, physical health, psychological diagnosis and treatments.

    Measured: 2 year for Group 1, 2, 3

  18. Health behaviours

    Self-report: physical activity, habits related to smoking, alcohol use, caffein, food and fluid intake. Social media use and leisure time.

    Measured: Baseline for Group 1, 2, 3

  19. Health behaviours

    Self-report: physical activity, habits related to smoking, alcohol use, caffein, food and fluid intake. Social media use and leisure time.

    Measured: 6 months for Group 2

  20. Health behaviours

    Self-report: physical activity, habits related to smoking, alcohol use, caffein, food and fluid intake. Social media use and leisure time.

    Measured: 1 year for Group 1, 2, 3

  21. Health behaviours

    Self-report: physical activity, habits related to smoking, alcohol use, caffein, food and fluid intake. Social media use and leisure time.

    Measured: 1.5 year Group 2

  22. Health behaviours

    Self-report: physical activity, habits related to smoking, alcohol use, caffein, food and fluid intake. Social media use and leisure time.

    Measured: 2 year for Group 1, 2, 3

  23. Sociodemographic data

    Self-report: country of birth, gender, sexual identity, living situation, employment, education.

    Measured: Baseline for Group 1, 2, 3

  24. Sociodemographic data

    Self-report: country of birth, gender, sexual identity, living situation, employment, education.

    Measured: 6 months for Group 2

  25. Sociodemographic data

    Self-report: country of birth, gender, sexual identity, living situation, employment, education.

    Measured: 1 year for Group 1, 2, 3

  26. Sociodemographic data

    Self-report: country of birth, gender, sexual identity, living situation, employment, education.

    Measured: 1.5 year Group 2

  27. Sociodemographic data

    Self report: country of birth, gender, sexual identity, living situation, employment, education.

    Measured: 2 year for Group 1, 2, 3

  28. Social factors

    Self-report: sense of community and belonging, and experience of violence and harassment

    Measured: Baseline for Group 1, 2, 3

  29. Social factors

    Self-report: sense of community and belonging, and experience of violence and harassment

    Measured: 6 months for Group 2

  30. Social factors

    Selfreport: sense of community and belonging, and experience of violence and harassment

    Measured: 1 year for Group 1, 2, 3

  31. Social factors

    Self-report: sense of community and belonging, and experience of violence and harassment

    Measured: 1.5 year Group 2

  32. Social factors

    Self-report: sense of community and belonging, and experience of violence and harassment

    Measured: 2 year for Group 1, 2, 3

  33. Explorative identification of biomarkers

    Optional at home blood sample, extraction and analysis of about 800 biomarkers and ratios of metabolic pathways, including steroid-, hormone-, neurotransmitter- and lipid regulation

    Measured: Baseline for Group 2, 3

  34. Explorative identification of biomarkers

    At home blood sample, extraction and analysis of about 800 biomarkers and ratios of metabolic pathways, including steroid-, hormone-, neurotransmitter- and lipid regulation

    Measured: 6 months for Group 2, 3

  35. Behavioral test, approach-avoidance conflict

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as approach-avoidance conflict.

    Measured: Baseline for Group 1, 2, 3

  36. Behavioral test, emotional regulation

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as emotional regulation.

    Measured: Baseline for Group 1, 2, 3

  37. Behavioral test, risk-taking

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as risk-taking.

    Measured: Baseline for Group 1, 2, 3

  38. Behavioral test, influence of ambiguity

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as influence of ambiguity.

    Measured: Baseline for Group 1, 2, 3

  39. Behavioral test, approach-avoidance conflict

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as approach-avoidance conflict.

    Measured: 1 year for Group 1, 2, 3

  40. Behavioral test, emotional regulation

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as emotional regulation.

    Measured: 1 year for Group 1, 2, 3

  41. Behavioral test, risk-taking

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as risk-taking.

    Measured: 1 year for Group 1, 2, 3

  42. Behavioral test, influence of ambiguity

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as influence of ambiguity.

    Measured: 1 year for Group 1, 2, 3

  43. Behavioral test, approach-avoidance conflict

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as approach-avoidance conflict.

    Measured: 2 year for Group 1, 2, 3

  44. Behavioral test, emotional regulation

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as emotional regulation.

    Measured: 2 year for Group 1, 2, 3

  45. Behavioral test, risk-taking

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as risk-taking.

    Measured: 2 year for Group 1, 2, 3

  46. Behavioral test, influence of ambiguity

    Data from online, remote behavioural tests. Measures of basic psychological mechanisms of importance for mental health such as influence of ambiguity.

    Measured: 2 year for Group 1, 2, 3

  47. Change in curiosity

    Self Report: Five-Dimensional Curiosity Scale Revised (5DCR). Swedish version. 7 selected items from Five-Dimensional Curiosity Scale Revised (5DCR). 7-point scale ranging from 1 = 'does not describe me' to 7 = 'describes me completely'.

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  48. Change in curiosity

    Self-report: Five-Dimensional Curiosity Scale Revised (5DCR). Swedish version. 7 selected items from Five-Dimensional Curiosity Scale Revised (5DCR). 7-point scale ranging from 1 = 'does not describe me' to 7 = 'describes me completely'.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

  49. Change in perceived meaningfulness of leisure

    Self-report: 1 item. 4-point scale ranging from not at all meaningful (0) to absolutely meaningful (4).

    Measured: Baseline, 1 year, 2 year for Group 1 and 3

  50. Change in perceived meaningfulness of leisure

    Self-report: 1 item. 4-point scale ranging from not at all meaningful (0) to absolutely meaningful (4).

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 year for Group 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2024
  2. Study start12 Aug 2024 (estimated)
  3. Primary completion31 Mar 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
3,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06490120
Sponsor's protocol ID
UU20230127
Acronym
UPIC
Status last verified
Jun 2024
First submitted
31 May 2024
Last updated
8 Jul 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mental Health Issue and Depression, Anxiety, run by Uppsala University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pernilla Asenlof, PhD (+ 46 18 471 47 68, pernilla.asenlof@uu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in anxiety symptoms (time frame: Baseline, 1 year, 2 year for Group 1 and 3). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in